Sustaining Quality Improvement and Patient Outcomes in North West London


The North West London (NWL) Diabetes Improvement Programme began in 2014 in five Clinical Commissioning Groups (CCGs) and has now spread to eight. It has achieved continued quality improvement in key diabetes metrics, including: improvements in nine key care processes; a 12% improvement in treatment target achievement (HbA1c ≤ 58, BP ≤ 140/80, Cholesterol ≤ 4); a 30% increase in structured education attendance in the past year, reaching almost 10% of the prevalent diabetes population; plus a total of 11,473 NHS Diabetes Prevention Programme (NDPP) referrals in 2018/19. The programme operates a large-scale, ongoing clinician education initiative, including 10-point training in secondary care. The Know Diabetes information and support service is about to relaunch, providing a single point of referral, diabetes education and multi-channel campaigns to all patients with diabetes and Non-diabetic hyperglycaemia (NDH) in NWL. The programme is beginning to show impact on diabetes outcomes, including an 8% reduction in diabetes foot admissions in 2018/19 and reductions in myocardial infarction (MI), acute kidney injury and renal failure. The NWL Diabetes Quality, Innovation, Productivity and Prevention (QIPP) scheme this year aimed to show prescribing savings through lifestyle change and complications savings.

Back to the top

QiC Diabetes Winner 2019
Best Practice in Dissemination and Sustainability Award
Sustaining Quality Improvement and Patient Outcomes in North West London
by North West London Health and Care Partnership


Previous_entry.docx - 210.8 KB

Quality In Care Diabetes

QiC Diabetes 2020 Awards Announced

Watch the livestream recording

The Results Brochure is now available to download and share

Click here for a full list of results

  • 2021 KEY DATES
  • To be announced
QiC Diabetes is partnered by:
Supported by: